Randomized controlled trial of an 8-week intervention combining self-care and hypnosis for post-treatment cancer patients: study protocol.

Abstract:

BACKGROUND:Cancer has a lot of consequences on patients' quality of life (such as cancer-related fatigue (CRF), sleep difficulties and emotional distress) and on patients' partners and their relationship, such as distress and communication difficulties. These consequences are undertreated, and interventions based on hypnosis often focus on breast cancer patients only. This paper describes the study protocol of a longitudinal randomized controlled trial aiming to assess the efficacy of an 8-week intervention combining hypnosis and self-care to improve cancer patients' CRF, sleep and emotional distress and to indirectly improve their partners' distress. METHODS:A power analysis required a total sample of 88 patients. To test the efficacy of the intervention, results of the experimental group receiving the intervention will be compared to those of the control group. Data will be collected by questionnaires, relaxation tasks, an attentional bias task, and everyday life assessments measured at four different times: 1.) before inclusion in the study (baseline); 2.) after the intervention; and 3.) at 4- and 12-month follow-up. Partners' symptoms will also be evaluated with questionnaires at the same measurement times. DISCUSSION:There is a growing interest in alternative approaches (such as hypnosis) in addition to standard therapies in oncology settings. The results of this study should be useful for improving knowledge about long-term efficacy of hypnosis-based group interventions for CRF, sleep and distress among all types of cancer patients and their partners, and to better understand the mechanisms of emotional regulation in cancer patients through the attentional bias task. TRIAL REGISTRATION:ClinicalTrials.gov (NCT03144154). Retrospectively registered on the 1st of May, 2017.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Grégoire C,Faymonville ME,Vanhaudenhuyse A,Charland-Verville V,Jerusalem G,Bragard I

doi

10.1186/s12885-018-5046-6

subject

Has Abstract

pub_date

2018-11-15 00:00:00

pages

1113

issue

1

issn

1471-2407

pii

10.1186/s12885-018-5046-6

journal_volume

18

pub_type

杂志文章
  • Prognostic models for breast cancer: a systematic review.

    abstract:BACKGROUND:Breast cancer is the most common cancer in women worldwide, with a great diversity in outcomes among individual patients. The ability to accurately predict a breast cancer outcome is important to patients, physicians, researchers, and policy makers. Many models have been developed and tested in different set...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5442-6

    authors: Phung MT,Tin Tin S,Elwood JM

    更新日期:2019-03-14 00:00:00

  • Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.

    abstract:BACKGROUND:Extravasation of circulating cancer cells is a key event of metastatic dissemination that is initiated by the adhesion of cancer cells to endothelial cells. It requires interactions between adhesion receptors on endothelial cells and their counter-receptors on cancer cells. Notably, E-selectin, a major endot...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-285

    authors: Porquet N,Poirier A,Houle F,Pin AL,Gout S,Tremblay PL,Paquet ER,Klinck R,Auger FA,Huot J

    更新日期:2011-07-01 00:00:00

  • The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models.

    abstract:BACKGROUND:The GABARAP family members (GABARAP, GABARAPL1/GEC1 and GABARAPL2 /GATE-16) are involved in the intracellular transport of receptors and the autophagy pathway. We previously reported that GABARAPL1 expression was frequently downregulated in cancer cells while a high GABARAPL1 expression is a good prognosis m...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1761-4

    authors: Hervouet E,Claude-Taupin A,Gauthier T,Perez V,Fraichard A,Adami P,Despouy G,Monnien F,Algros MP,Jouvenot M,Delage-Mourroux R,Boyer-Guittaut M

    更新日期:2015-10-17 00:00:00

  • Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy.

    abstract:BACKGROUND:MEK1 (MAP2K1) and MEK2 (MAP2K2) are closely related dual-specificity protein kinases which function by phosphorylating both serine/threonine and tyrosine residues of their substrates ERK1 and ERK2, controlling fundamental cellular processes that include cell growth and proliferation. To investigate the progn...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2869-x

    authors: Gomez-Millan J,Pajares B,Perez-Villa L,Carnero A,Alvarez M,De Luque V,Rivas F,Trigo JM,Toledo MD,Alba E,Medina JA

    更新日期:2016-10-28 00:00:00

  • Verbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancer.

    abstract:BACKGROUND:We investigated the role of the HIPK2-p53 signaling pathway in tumorigenesis and resistance to the drug Verbascoside (VB) in colorectal cancer (CRC), using in vivo and in vitro experiments. METHODS:Primary human CRC samples and normal intestinal tissues from patients were analyzed for HIPK2 expression by im...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-747

    authors: Zhou L,Feng Y,Jin Y,Liu X,Sui H,Chai N,Chen X,Liu N,Ji Q,Wang Y,Li Q

    更新日期:2014-10-05 00:00:00

  • Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.

    abstract:BACKGROUND:CD73 is one of the critical component in the formation of immunosuppressive microenvironment in cancers. We aimed to provide an overview of the current status of CD73 expression and its relationship with clinicopathlogical features and prognosis in different cancers. METHODS:PubMed, Web of Science, EMBASE a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4073-7

    authors: Jiang T,Xu X,Qiao M,Li X,Zhao C,Zhou F,Gao G,Wu F,Chen X,Su C,Ren S,Zhai C,Zhou C

    更新日期:2018-03-07 00:00:00

  • The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.

    abstract:BACKGROUND:HIV infection is associated with a higher incidence of precancerous cervical lesions and their progression to invasive cervical cancer (ICC). Zambia is a global epicenter of HIV and ICC, yet the overall burden of cervical pre-cancer [cervical intraepithelial neoplasia 3 (CIN3)] and ICC among its HIV positive...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1558-5

    authors: Bateman AC,Katundu K,Mwanahamuntu MH,Kapambwe S,Sahasrabuddhe VV,Hicks ML,Chi BH,Stringer JS,Parham GP,Chibwesha CJ

    更新日期:2015-07-24 00:00:00

  • Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.

    abstract:BACKGROUND:Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cause of cancer death in the US. The protein kinase D (PKD) family has emerged as a promising target for cancer therapy with PKD1 being most intensively studied; however, its role in HNSCC has not been investigated. METHODS:The expression of...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4965-6

    authors: Zhang L,Li Z,Liu Y,Xu S,Tandon M,Appelboom B,LaValle CR,Chiosea SI,Wang L,Sen M,Lui VWY,Grandis JR,Wang QJ

    更新日期:2018-11-12 00:00:00

  • Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.

    abstract:BACKGROUND:The causal association between persistent human papillomavirus (HPV) infection and cervical cancer has been established, but the mechanisms that favor HPV persistence in cervical cells are still unknown. The diminished capability of the immune system to control and resolve HPV infection is one of several hyp...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-618

    authors: Gillio-Tos A,Bicalho Mda G,Fiano V,Grasso C,Tarallo V,De Marco L,Trevisan M,Xavier M,Slowik R,Carvalho NS,Maestri CA,Lacerda HM,Zugna D,Richiardi L,Merletti F

    更新日期:2012-12-24 00:00:00

  • The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.

    abstract:BACKGROUND:Topoisomerase II alpha (TOP2A) protein has been shown to be a proliferation marker associated with tumor grade and Ki67 index. The prognostic effect of TOP2A seems different among different subtypes of breast cancer. The current study evaluated the prognostic impact of TOP2A protein on luminal breast cancer....

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4170-7

    authors: An X,Xu F,Luo R,Zheng Q,Lu J,Yang Y,Qin T,Yuan Z,Shi Y,Jiang W,Wang S

    更新日期:2018-03-27 00:00:00

  • Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.

    abstract:BACKGROUND:Long-term survival in numerous cancers often correlates with specific whole transcriptome profiles or the expression patterns of smaller numbers of transcripts. In some instances, these are better predictors of survival than are standard classification methods such as clinical stage or hormone receptor statu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06756-x

    authors: Mandel J,Avula R,Prochownik EV

    更新日期:2020-04-07 00:00:00

  • INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.

    abstract:BACKGROUND:Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells. Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor β (TGFβ) in situ, w...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2473-0

    authors: Yu Y,Huang R,Zong X,He X,Mo W

    更新日期:2016-07-07 00:00:00

  • Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.

    abstract:BACKGROUND:Accurate staging of colorectal cancer (CRC) with clinicopathological parameters is important for predicting prognosis and guiding treatment but provides no information about organ site of metastases. Patterns of genomic aberrations in primary colorectal tumors may reveal a chromosomal signature for organ spe...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-662

    authors: Bruin SC,Klijn C,Liefers GJ,Braaf LM,Joosse SA,van Beers EH,Verwaal VJ,Morreau H,Wessels LF,van Velthuysen ML,Tollenaar RA,Van't Veer LJ

    更新日期:2010-12-02 00:00:00

  • Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study.

    abstract:BACKGROUND:Little information is available concerning how patient delay may be affected by mass disasters. The main objectives of the present study are to identify whether there was a post-disaster increase in the risk of experiencing patient delay among breast cancer patients in an area affected by the 2011 triple dis...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3412-4

    authors: Ozaki A,Nomura S,Leppold C,Tsubokura M,Tanimoto T,Yokota T,Saji S,Sawano T,Tsukada M,Morita T,Ochi S,Kato S,Kami M,Nemoto T,Kanazawa Y,Ohira H

    更新日期:2017-06-19 00:00:00

  • Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.

    abstract:BACKGROUND:Preclinical research indicate that vascular disrupting agent (VDA) treatment induces extensive tumor death but also a systemic mobilization of bone marrow derived cells including endothelial progenitor cells (EPC) leading to revascularization and renewed growth within the residual tumor. This study investiga...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2568-7

    authors: Nguyen L,Fifis T,Christophi C

    更新日期:2016-07-26 00:00:00

  • Correction to: Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.

    abstract::Following publication of the original article [1], the authors reported an error in Fig. 6c and in the figure legends for Fig. 5c and Fig. 6c. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-020-6552-x

    authors: Nilsson G,Kannius-Janson M

    更新日期:2020-01-23 00:00:00

  • Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study.

    abstract:BACKGROUND:In China, there are currently no approved therapies for the treatment of metastatic renal cell carcinoma (mRCC) following progression with vascular endothelial growth factor (VEGF)-targeted agents. In the phase 3 RECORD-1 trial, the mammalian target of rapamycin (mTOR) inhibitor everolimus afforded clinical ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-13-136

    authors: Guo J,Huang Y,Zhang X,Zhou F,Sun Y,Qin S,Ye Z,Wang H,Jappe A,Straub P,Pirotta N,Gogov S

    更新日期:2013-03-21 00:00:00

  • Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.

    abstract:BACKGROUND:Due to improvements in imaging and radiological techniques as well as the use of chemotherapy, distant metastasis has become the predominant mode of treatment failure in patients with locally advanced nasopharyngeal carcinoma (LA-NPC). Platinum-based systemic chemotherapy has shown survival benefits and is n...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3080-4

    authors: Ke LR,Xia WX,Qiu WZ,Huang XJ,Yang J,Yu YH,Liang H,Liu GY,Ye YF,Xiang YQ,Guo X,Lv X

    更新日期:2017-02-15 00:00:00

  • Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.

    abstract:BACKGROUND:Expression of Nodal, a member of the TGF-β superfamily, is commonly absent in differentiated tissues, while its re-expression occurs in a variety of human malignancy. However, little is known about its involvement in ovarian tumorigenesis. Herein, we focused on the functional roles of Nodal in ovarian endome...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5539-y

    authors: Miura R,Yokoi A,Matsumoto T,Oguri Y,Hashimura M,Tochimoto M,Kajita S,Saegusa M

    更新日期:2019-04-03 00:00:00

  • Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (WJOG

    abstract:BACKGROUND:Bevacizumab, a humanized antibody to vascular endothelial growth factor (VEGF), shows clinical activity against human cancer, with its addition to standard chemotherapy having been found to improve outcome in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). However, there have been no e...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/1471-2407-12-327

    authors: Takeda M,Okamoto I,Yamanaka T,Nakagawa K,Nakanishi Y

    更新日期:2012-08-01 00:00:00

  • Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer.

    abstract:BACKGROUND:We aimed to evaluate the prognostic value of quality of life (QOL) for predicting survival among disease-free survivors of surgically-treated lung cancer after the completion of cancer treatment. METHODS:We administered the European Organization for Research and Treatment of Cancer Quality of Life Questionn...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2504-x

    authors: Yun YH,Kim YA,Sim JA,Shin AS,Chang YJ,Lee J,Kim MS,Shim YM,Zo JL

    更新日期:2016-07-20 00:00:00

  • Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.

    abstract:BACKGROUND:Metformin is a biguanide oral hypoglycaemic agent commonly used for the treatment of type 2 diabetes mellitus. In addition to its anti-diabetic effect, metformin has also been associated with a reduced risk of cancer incidence of a number of solid tumours, including prostate cancer (PCa). However, the underl...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-017-3458-3

    authors: Crawley D,Chandra A,Loda M,Gillett C,Cathcart P,Challacombe B,Cook G,Cahill D,Santa Olalla A,Cahill F,George G,Rudman S,Van Hemelrijck M

    更新日期:2017-07-21 00:00:00

  • A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.

    abstract:BACKGROUND:Colorectal cancer is a major public health issue worldwide. Interleukin-17 (IL-17) and Th17 (T-helper cell type 17)-related molecules are involved in tumor development and in resistance to bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody used in association with chemotherapy in met...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3210-z

    authors: Lereclus E,Tout M,Girault A,Baroukh N,Caulet M,Borg C,Bouché O,Ternant D,Paintaud G,Lecomte T,Raoul W

    更新日期:2017-03-27 00:00:00

  • Modeling the effect of age in T1-2 breast cancer using the SEER database.

    abstract:BACKGROUND:Modeling the relationship between age and mortality for breast cancer patients may have important prognostic and therapeutic implications. METHODS:Data from 9 registries of the Surveillance, Epidemiology, and End Results Program (SEER) of the United States were used. This study employed proportional hazards...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-130

    authors: Tai P,Cserni G,Van De Steene J,Vlastos G,Voordeckers M,Royce M,Lee SJ,Vinh-Hung V,Storme G

    更新日期:2005-10-08 00:00:00

  • Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.

    abstract:BACKGROUND:Treatment of tonsil cancer, a subset of oropahryngeal cancer, varies between surgery and radiotherapy. Well-designed studies in tonsil cancer have been rare and it is still controversial which treatment is optimal. This study aimed to assess the outcome and failure patterns in tonsil cancer patients treated ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3571-3

    authors: Song S,Wu HG,Lee CG,Keum KC,Kim MS,Ahn YC,Oh D,Park HJ,Lee SW,Park G,Moon SH,Cho KH,Kim YS,Won Y,Oh YT,Kim WT,Jeong JU

    更新日期:2017-08-30 00:00:00

  • Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.

    abstract:BACKGROUND:To date, the clinical benefit of topical steroid use has only been demonstrated for radiation dermatitis induced by 50-60 Gy irradiation in breast cancer. However, these agents are also often used clinically for the control of radiation dermatitis induced by high-dose (>60Gy) irradiation with chemotherapy in...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4763-1

    authors: Zenda S,Yamaguchi T,Yokota T,Miyaji T,Mashiko T,Tanaka M,Yonemura M,Takeno M,Okano T,Kawasaki T,Nakamori Y,Ishii S,Shimada S,Kanamaru M,Uchitomi Y

    更新日期:2018-09-06 00:00:00

  • Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.

    abstract:BACKGROUND:Signaling pathways that converge on two different transcription factor complexes, NFkappaB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. METHODS:Two cell line models of tamoxifen-resistant ER-positive breast cancer, MCF7/HER2 and B...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-59

    authors: Zhou Y,Yau C,Gray JW,Chew K,Dairkee SH,Moore DH,Eppenberger U,Eppenberger-Castori S,Benz CC

    更新日期:2007-04-03 00:00:00

  • Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.

    abstract:BACKGROUND:Microarray gene-profiling of invasive breast cancer has identified different subtypes including luminal A, luminal B, HER2-overexpressing and basal-like groups. Basal-like invasive breast cancer is associated with a worse prognosis. However, the prognosis of basal-like ductal carcinoma in situ (DCIS) is stil...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-653

    authors: Zhou W,Jirström K,Johansson C,Amini RM,Blomqvist C,Agbaje O,Wärnberg F

    更新日期:2010-11-30 00:00:00

  • The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.

    abstract:BACKGROUND:Neoadjuvant systemic therapy (NST) is increasingly used in the treatment of breast cancer, yet it is clear that there is significant geographical variation in its use in the UK. This study aimed to examine stated practice across UK breast units, in terms of indications for use, radiological monitoring, patho...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07757-6

    authors: Whitehead I,Irwin GW,Bannon F,Coles CE,Copson E,Cutress RI,Dave RV,Gardiner MD,Grayson M,Holcombe C,Irshad S,O'Brien C,O'Connell RL,Palmieri C,Shaaban AM,Sharma N,Singh JK,Potter S,McIntosh SA,NeST Study Research Co

    更新日期:2021-01-22 00:00:00

  • Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori.

    abstract:BACKGROUND:H. pylori, whose infection increases tumor invasiveness and metastasis, is generally labelled as the strongest risk factor for the development of gastric cancer. It appears not to be a coincidence that there is also an overexpression of CXCR4 and an obvious involvement in gastric cancer metastasis. The aim o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-419

    authors: Zhao C,Lu X,Bu X,Zhang N,Wang W

    更新日期:2010-08-11 00:00:00